Medical 3pl giant Movianto is to be sold by parent company Celesio to US firm Owens & Minor for €130m. Celesio says it wants to divest of logistics arm Movianto, which has been part of the German-based company since 2004, to concentrate on its core sectors of pharmaceutical wholesaling and pharmacies, which accounts for 95% of the group’s business. It adds that the divestment will happen more swiftly than originally planned due to “the buyer’s reputation for quality and integrity”. […]
Kuehne + Nagel has signed a “transformational” new global contract with pharmaceutical materials provider GlaxoSmithKline (GSK).
Healthcare specialist operator Movianto has taken delivery of 32 Daf CFs in the first stage of a complete fleet refresh over the next 12 months.